Nova Scotia Health Partners with Medable for Decentralized Clinical Trial Technology to Improve Oncology Patient Access
Medable Inc. , the leading technology platform for clinical trials, announced that its decentralized clinical trial (DCT) platform was selected by the Nova Scotia Health Innovation Hub to increase the accessibility of oncology care for remote patients in rural Nova Scotia, with the long-term aim to improve patient access and trial diversity across Canada.
- Medable Inc. , the leading technology platform for clinical trials, announced that its decentralized clinical trial (DCT) platform was selected by the Nova Scotia Health Innovation Hub to increase the accessibility of oncology care for remote patients in rural Nova Scotia, with the long-term aim to improve patient access and trial diversity across Canada.
- View the full release here: https://www.businesswire.com/news/home/20230202005388/en/
For oncology patients living in rural parts of Nova Scotia, accessing follow-up care can be challenging, especially when it requires lengthy travel time and costs. - That’s why Nova Scotia Health is partnering with Medable on a two-year pilot study, launched in January 2023, to improve access to clinical trials.
- Learn more about Medable’s partnership with Nova Scotia Health and other leaders at the 14th Annual SCOPE Conference (February 6-9, 2023) in Orlando, FL – booth #613.